United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - carisoprodol (unii: 21925k482h) (carisoprodol - unii:21925k482h) - carisoprodol 200 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 0.3 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine 15 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - tetrabenazine (unii: z9o08yrn8o) (tetrabenazine - unii:z9o08yrn8o) - tetrabenazine 12.5 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 650 mg - antacid relieves: - acid indigestion - heartburn - sour stomach - upset stomach associated with these symptoms

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - chlorthalidone 25 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - phentermine hydrochloride (unii: 0k2i505otv) (phentermine - unii:c045tql4wp) - phentermine hydrochloride 37.5 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - cevimeline hydrochloride (unii: p81q6v85np) (cevimeline - unii:k9v0cdq56e) - cevimeline hydrochloride 30 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - nadolol (unii: fen504330v) (nadolol - unii:fen504330v) - nadolol tablets are indicated for the long-term management of patients with angina pectoris. nadolol tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nadolol tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure educati

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - carbidopa (unii: mnx7r8c5vo) (carbidopa anhydrous - unii:kr87b45rgh) - carbidopa anhydrous 25 mg